Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program

por Vleugels, Jasper L. A., Greuter, Marjolein J. E., Hazewinkel, Yark, Coupé, Veerle M. H., Dekker, Evelien
Publicado 2017

Resilience of a FIT screening programme against screening fatigue: a modelling study

por Greuter, Marjolein J. E., Berkhof, Johannes, Canfell, Karen, Lew, Jie-Bin, Dekker, Evelien, Coupé, Veerle M. H.
Publicado 2016

Self-monitoring combined with patient-initiated care in RA patients with low disease activity: cost-effectiveness analysis of an RCT

por Seppen, Bart F, Greuter, Marjolein J E, Wiegel, Jimmy, ter Wee, Marieke M, Boers, Maarten, Nurmohamed, Michael T, Bos, Wouter H
Publicado 2023

Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening

por Bronzwaer, Maxime E. S., Greuter, Marjolein J. E., Bleijenberg, Arne G. C., IJspeert, Joep E. G., Dekker, Evelien, Coupé, Veerle M. H.
Publicado 2018

Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients

por Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Publicado 2020

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients

por Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Publicado 2021

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data

por Jongeneel, Gabrielle, Klausch, Thomas, van Erning, Felice N., Vink, Geraldine R., Koopman, Miriam, Punt, Cornelis J.A., Greuter, Marjolein J.E., Coupé, Veerle M.H.
Publicado 2019

Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study

por Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Twisk, Jos W. R., Koopman, Miriam, Punt, Cornelis J. A., Vink, Geraldine R., Coupé, Veerle M. H.
Publicado 2021

Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening

por Worthington, Joachim, van Wifferen, Francine, Sun, Zhuolu, de Jonge, Lucie, Lew, Jie-Bin, Greuter, Marjolein J.E., van den Puttelaar, Rosita, Feletto, Eleonora, Lansdorp-Vogelaar, Iris, Coupé, Veerle M.H., Ein Yong, Jean Hai, Canfell, Karen
Publicado 2023

Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study

por van Wifferen, Francine, de Jonge, Lucie, Worthington, Joachim, Greuter, Marjolein J.E., Lew, Jie-Bin, Nadeau, Claude, van den Puttelaar, Rosita, Feletto, Eleonora, Yong, Jean H.E., Lansdorp-Vogelaar, Iris, Canfell, Karen, Coupé, Veerle M.H.
Publicado 2022

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study

por de Jonge, Lucie, Worthington, Joachim, van Wifferen, Francine, Iragorri, Nicolas, Peterse, Elisabeth F P, Lew, Jie-Bin, Greuter, Marjolein J E, Smith, Heather A, Feletto, Eleonora, Yong, Jean H E, Canfell, Karen, Coupé, Veerle M H, Lansdorp-Vogelaar, Iris
Publicado 2021

Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)

por Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Medema, Jan P., Kandimalla, Raju, Goel, Ajay, Bujanda, Luis, Meijer, Gerrit A., Fijneman, Remond J. A., van Oijen, Martijn G. H., Ijzermans, Jan, Punt, Cornelis J. A., Vink, Geraldine R., Coupé, Veerle M. H.
Publicado 2020

Concordance in measurable residual disease result after first and second induction cycle in acute myeloid leukemia: An outcome- and cost-analysis

por Tettero, Jesse M., Al-Badri, Waleed K. W., Ngai, Lok Lam, Bachas, Costa, Breems, Dimitri A., van Elssen, Catharina H. M. J., Fischer, Thomas, Gjertsen, Bjorn T., van Gorkom, Gwendolyn N. Y., Gradowska, Patrycja, Greuter, Marjolein J. E., Griskevicius, Laimonas, Juliusson, Gunnar, Maertens, Johan, Manz, Markus G., Pabst, Thomas, Passweg, Jakob, Porkka, Kimmo, Löwenberg, Bob, Ossenkoppele, Gert J., Janssen, Jeroen J. W. M., Cloos, Jacqueline
Publicado 2022